Hepatocellular adenoma: Should phenotypic classification direct management?

Nature Reviews Gastroenterology and Hepatology

Volumn 6, Issue 12, 2009, Pages 697-698

  Terkivatan, Türkan ^a   Ijzermans, Jan N M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; SERUM AMYLOID A;

ARTIFICIAL EMBOLISM; BENIGN TUMOR; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER BIOPSY; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SHORT SURVEY; TUMOR CLASSIFICATION;

ADENOMA, LIVER CELL; GENOTYPE; HUMANS; LIVER NEOPLASMS; PHENOTYPE;

EID: 74949138680     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2009.199     Document Type: Short Survey

References (11)

1. Rooks, J. B. et al. epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242, 644-648 (1979).
2. Cobey, F. C. & salem, R. R. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am. J. Surg. 187, 181-191 (2004).
3. Bioulac-sage, P., Laumonier, H., Laurent, C., Zucman-Rossi, J. & Balabaud, C. Hepatocellular adenoma: what is new in 2008. Hepatol. Int. 2, 316-321 (2008).
4. Bioulac-sage, P. et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50, 481-489 (2009).
5. Terkivatan, T. et al. indications and long-term outcome of treatment for benign hepatic tumours: a critical appraisal. Arch. Surg. 136, 1033-1038 (2001).
6. Lee, H. Y. et al. Detection and characterization of focal hepatic lesions: comparative study of MDCT and gadobenate dimeglumine-enhanced MR imaging. Clin. Imaging 32, 287-295 (2008).
7. Terkivatan, T. & iJzermans, J. n. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRi including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study. J. Magn. Reson. Imaging 24, 864-872 (2006).
8. Atwell, T. D. et al. successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. AJR Am. J. Roentgenol. 184, 828-831 (2005).
9. van der sluis, F. J. et al. Hepatocellular adenoma: cost-effectiveness of different treatment strategies. Radiology 252, 737-746 (2009).
10. van der windt, D. J., Kok, n. F., de Man, R. A. & ijzermans, J. n. Diagnosis and treatment of hepatocellular adenoma in the netherlands: similarities and differences [Dutch]. Ned. Tijdschr. Geneeskd. 151, 1345-1351 (2007).
11. van der windt, D. J. et al. Case-orientated approach to the management of hepatocellular adenoma. Br. J. Surg. 93, 1495-1502 (2006).